Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for bone metastases with moderate anemia
ChiCTR1800016845Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thalidomide in bone metastases and anaemia (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Hemoglobin. Started Jul 2018; status: recruiting.
02
Drugs
thalidomide
03
Conditions
bone metastasesanaemia
Beyond the preview
Go deeper on ChiCTR1800016845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016845.